Human C1-Esterase Inhibitor vs Trastuzumab

Human C1-Esterase Inhibitor vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Human C1-Esterase Inhibitor and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab — 28 days.

Chemical Properties

Type: Human C1-Esterase Inhibitor — Protein; Trastuzumab — Antibody.